BCLC GROUP (@bclc_group) 's Twitter Profile
BCLC GROUP

@bclc_group

The BCLC group was created in 1986. We are a multidisciplinary group dedicated to the management and research in liver cancer.

ID: 4493403256

linkhttp://www.bclc.cat calendar_today15-12-2015 15:32:36

1,1K Tweet

4,4K Followers

212 Following

BCLC GROUP (@bclc_group) 's Twitter Profile Photo

🚨 Ending the year with a major update! 🚨 New @EASL Guidelines for #HCC 2024 📑 #EASL reaffirms the BCLC GROUP strategy as the prognostic classification and highlights multidisciplinary, patient-centered care as pillars of healthcare quality. journal-of-hepatology.eu/article/S0168-…

🚨 Ending the year with a major update! 🚨

New @EASL Guidelines for #HCC  2024 📑

#EASL reaffirms the <a href="/BCLC_group/">BCLC GROUP</a>  strategy as the prognostic classification and highlights multidisciplinary, patient-centered care as pillars of healthcare quality.

journal-of-hepatology.eu/article/S0168-…
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

Pattern of progression in different cancer types emerges as a key predictor for post-progression OS. We first described it in hepatocellular carcinoma in doi.org/10.1002/hep.26… and commented in extense its value in pubmed.ncbi.nlm.nih.gov/31371809/. Fully validated now.

Journal of Hepatology (@jhepatology) 's Twitter Profile Photo

📌In our December issue Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection Read it here👉journal-of-hepatology.eu/article/S0168-… Ezequiel Mauro Alejandro Forner BCLC GROUP #LiverTwitter

📌In our December issue

Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection

Read it here👉journal-of-hepatology.eu/article/S0168-…

<a href="/ezemauro_ok/">Ezequiel Mauro</a>
<a href="/Alexfornergon/">Alejandro Forner</a>
<a href="/BCLC_group/">BCLC GROUP</a> 
#LiverTwitter
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

✨ Bye Bye 2024! 🎉 To our amazing #BCLCCommunity, thank you for being part of this year. 💬 Let’s carry this energy into 2025 with more connections, growth, and success. Cheers to another amazing year ahead! 🥂 #BCLC #ByeBye2024 #HappyNewYear Hospital Clínic CIBERehd IDIBAPS

✨ Bye Bye 2024! 🎉
To our amazing #BCLCCommunity, thank you for being part of this year.
💬 Let’s carry this energy into 2025 with more connections, growth, and success. Cheers to another amazing year ahead! 🥂
#BCLC #ByeBye2024 #HappyNewYear

<a href="/hospitalclinic/">Hospital Clínic</a> <a href="/CIBERehd/">CIBERehd</a> <a href="/idibaps/">IDIBAPS</a>
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

🔄 Desde BCLC GROUP nos sumamos al agradecimiento a Asociación Española Contra el Cáncer por su apoyo. Este esfuerzo multidisciplinar reúne a 14 centros, liderados por Maria Reig junto con #GregorioMarañón, #ParcTaulí, #HospitalOviedo, #CUN, #CIMA, #CNTA, #UN 💪🤝 🌟 #InvestigandoEnCáncer

🔄 Desde <a href="/BCLC_group/">BCLC GROUP</a> nos sumamos al agradecimiento a <a href="/ContraCancerEs/">Asociación Española Contra el Cáncer</a> por su apoyo. Este esfuerzo multidisciplinar reúne a 14 centros, liderados por <a href="/ma5RN/">Maria Reig</a> junto con #GregorioMarañón, #ParcTaulí, #HospitalOviedo, #CUN, #CIMA, #CNTA, #UN  💪🤝
🌟 #InvestigandoEnCáncer
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

Two intense weeks at the BCLC! 🌟 Ignacio Roca (Argentina) & Antonio De Rosa (Italy) kick off the 2025 rotations with energy, teamwork & connections. Next stop: LCS 2025! 🚀 #BCLC2025 #LCS2025 🎯 easl.eu/event/liver-ca…

Two intense weeks at the BCLC! 🌟 Ignacio Roca (Argentina) &amp; <a href="/Antonio32591734/">Antonio De Rosa</a>  (Italy) kick off the 2025 rotations with energy, teamwork &amp; connections. Next stop: LCS 2025! 🚀 #BCLC2025 #LCS2025 🎯 easl.eu/event/liver-ca…
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

Resilience & patience pay off! Even after curing #HCV, the big challenge remains: #managing the residual risk of #HCC Promoting healthy #lifestylechanges & a multidisciplinary, nurse-led approach is key Read more: rdcu.be/d8v5l Barcelona Clinic Viral Hepatitis Group Hospital Clínic IDIBAPS

BCLC GROUP (@bclc_group) 's Twitter Profile Photo

And finally a group picture with current members (physicians and nurses) and current and past fellows. A happy group with cohessive philosophy is a blessing and provides results for clinical care. No success without human touch!!@hospitalclinic IDIBAPS CIBERehd Asociación Española Contra el Cáncer

And finally a group picture with current members (physicians and nurses) and current and past fellows. A happy group with cohessive philosophy is a blessing and provides results for clinical care. No success without human touch!!@hospitalclinic <a href="/idibaps/">IDIBAPS</a> <a href="/CIBERehd/">CIBERehd</a> <a href="/ContraCancerEs/">Asociación Española Contra el Cáncer</a>
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

Forgot to mention biologists runing lab studies!!! The point is that we never stratify by area of expertise. All profiles are united in action.

Digestive Cancers Europe (@dice_europe) 's Twitter Profile Photo

The most common form of Biliary tract cancer (BTC) is #Cholaniocarcinoma (CCA). CCA experts Dr. Alejandro Forner, Dr. Tamara Saurí and Dr. Ismael Macías from the Liver Cancer Unit, BCLC, Hospital Clínic, shared their insights on addressing CCA. ➡️digestivecancers.eu/liver-cancer-w… #CCA

The most common form of Biliary tract cancer (BTC) is #Cholaniocarcinoma (CCA).
CCA experts Dr. Alejandro Forner, Dr. Tamara Saurí and
Dr. Ismael Macías from the Liver Cancer Unit, BCLC, <a href="/hospitalclinic/">Hospital Clínic</a>, shared their insights on addressing CCA.
➡️digestivecancers.eu/liver-cancer-w…
#CCA
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

#WorldLiverDay should prime visibility and awareness in order to curb the impact of liver diseases (liver cancer included) in life expectancy. The BCLC is proud to be part of the effort at Hospital Clínic IDIBAPS CIBERehd Asociación Española Contra el Cáncer

EASLnews (@easlnews) 's Twitter Profile Photo

A critical discussion is underway at #EASLCongress as EASL and CIRSE examine the pros and cons of combining locoregional therapy with systemic treatment for hepatocellular carcinoma. Today’s session reviews the rationale behind combination approaches, explores emerging evidence

A critical discussion is underway at #EASLCongress as EASL and CIRSE examine the pros and cons of combining locoregional therapy with systemic treatment for hepatocellular carcinoma.

Today’s session reviews the rationale behind combination approaches, explores emerging evidence
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

Session about the challenges around systemic therapy just finished EASLnews Our very own Marco Sanduzzi Zamparelli exposed his BCLC thinking about how to navigate treatment sequencing. Clinical expertise is an important asset Hospital Clínic IDIBAPS CIBERehd Asociación Española Contra el Cáncer

Session about the challenges around systemic therapy just finished <a href="/EASLnews/">EASLnews</a> Our very own <a href="/MarcoSanduzzi/">Marco Sanduzzi Zamparelli</a> exposed his BCLC thinking about how to navigate treatment sequencing. Clinical expertise is an important asset <a href="/hospitalclinic/">Hospital Clínic</a> <a href="/idibaps/">IDIBAPS</a> <a href="/CIBERehd/">CIBERehd</a> <a href="/ContraCancerEs/">Asociación Española Contra el Cáncer</a>
IDIBAPS (@idibaps) 's Twitter Profile Photo

🆕Susana Puig is the new director of IDIBAPS Puig is a group leader, the head of the Dermatology Dept at Hospital Clínic and a professor at the UB. This triple affiliation confirms the campus model that integrates Research, Teaching and Assistance 👉f.mtr.cool/pklssgwyme

🆕Susana Puig is the new director of IDIBAPS

Puig is a group leader, the head of the Dermatology Dept at Hospital Clínic and a professor at the UB. This triple affiliation confirms the campus model that integrates Research, Teaching and Assistance

👉f.mtr.cool/pklssgwyme
BCLC GROUP (@bclc_group) 's Twitter Profile Photo

The BCLC update 2025 program is already available. Scheduled for Oct 27-28 with international experts that will prime an interactive event to debate all hot topics in liver cancer. A not to miss event!! Registration at inscripcions.academia.cat/form.php?id=30…

The BCLC update 2025 program is already available. Scheduled for Oct 27-28 with international experts that will prime an interactive event to debate all hot topics  in liver cancer. A not to miss event!! Registration at inscripcions.academia.cat/form.php?id=30…